Palisade Bio (PALI) Operating Leases (2019 - 2024)
Historic Operating Leases for Palisade Bio (PALI) over the last 6 years, with Q2 2024 value amounting to $24000.0.
- Palisade Bio's Operating Leases fell 8431.37% to $24000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $24000.0, marking a year-over-year decrease of 8431.37%. This contributed to the annual value of $90000.0 for FY2023, which is 5734.6% down from last year.
- Palisade Bio's Operating Leases amounted to $24000.0 in Q2 2024, which was down 8431.37% from $58000.0 recorded in Q1 2024.
- In the past 5 years, Palisade Bio's Operating Leases ranged from a high of $364000.0 in Q2 2022 and a low of $24000.0 during Q2 2024
- For the 5-year period, Palisade Bio's Operating Leases averaged around $162637.7, with its median value being $153000.0 (2023).
- As far as peak fluctuations go, Palisade Bio's Operating Leases soared by 11518.99% in 2022, and later plummeted by 8431.37% in 2024.
- Quarter analysis of 5 years shows Palisade Bio's Operating Leases stood at $112000.0 in 2020, then soared by 41.07% to $158000.0 in 2021, then skyrocketed by 33.54% to $211000.0 in 2022, then crashed by 57.35% to $90000.0 in 2023, then crashed by 73.33% to $24000.0 in 2024.
- Its Operating Leases stands at $24000.0 for Q2 2024, versus $58000.0 for Q1 2024 and $90000.0 for Q4 2023.